Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Debt (2018 - 2021)

Historic Non-Current Debt for Lipocine (LPCN) over the last 4 years, with Q1 2021 value amounting to $1.4 million.

  • Lipocine's Non-Current Debt fell 6923.22% to $1.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $1.4 million, marking a year-over-year decrease of 6923.22%. This contributed to the annual value of $2.3 million for FY2020, which is 4082.76% down from last year.
  • Latest data reveals that Lipocine reported Non-Current Debt of $1.4 million as of Q1 2021, which was down 6923.22% from $2.3 million recorded in Q4 2020.
  • Over the past 5 years, Lipocine's Non-Current Debt peaked at $8.7 million during Q1 2018, and registered a low of $1.4 million during Q1 2021.
  • For the 4-year period, Lipocine's Non-Current Debt averaged around $5.2 million, with its median value being $4.7 million (2020).
  • In the last 5 years, Lipocine's Non-Current Debt crashed by 2389.6% in 2020 and then crashed by 6923.22% in 2021.
  • Quarter analysis of 4 years shows Lipocine's Non-Current Debt stood at $6.9 million in 2018, then plummeted by 44.93% to $3.8 million in 2019, then crashed by 40.83% to $2.3 million in 2020, then crashed by 36.09% to $1.4 million in 2021.
  • Its Non-Current Debt stands at $1.4 million for Q1 2021, versus $2.3 million for Q4 2020 and $3.2 million for Q3 2020.